# OnCo record bright-peak-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bright-peak-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bright-peak-therapeutics" ;
  schema:name "Bright Peak Therapeutics"@en ;
  schema:description "Bright Peak Therapeutics makes immune medicines that combine a PD-1 checkpoint blocker with an immune-boosting signal aimed at T cells inside tumours. Its first such medicine entered an early trial in solid tumours, which has since stopped."@en ;
  schema:url <https://onco.cc/companies/bright-peak-therapeutics/>, <https://brightpeaktx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://brightpeaktx.com/>, <https://brightpeaktx.com/bright-peak-therapeutics-announces-90-million-in-series-c-financing-to-advance-first-in-class-pd1-il18-immunoconjugate-program-into-clinical-trials/>, <https://clinicaltrials.gov/study/NCT06779851> ;
  schema:addressCountry "CH" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/immunocytokines/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/site-specific-conjugation/> ;
  onco:targets <https://onco.cc/targets/pd1/> .